Back to Search
Start Over
US FDA grants breakthrough therapy designation to Inovio's INO-3107 to treat recurrent respiratory papillomatosis
- Source :
- PharmaBiz. September 9, 2023
- Publication Year :
- 2023
-
Abstract
- Inovio, a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, announced that the US Food and [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.764272393